No Prescription |
 |
 | ||
|
MELOSET MEL |
|
| ||
No Prescription » Prescription Drugs 10 » MELOSET MEL Melatonin is a hormone made by a part of the brain called the pineal (say: "pin-ee-all") gland. Melatonin may help our bodies know when it's time to go to sleep and when it's time to wake up. Melatonin supplements (in pill form) can also be taken. There are two types of melatonin that may be used in these pills: natural and synthetic (man-made). Natural melatonin is made from the pineal gland of animals. This form could be contaminated with a virus and is therefore not recommended. The synthetic form of melatonin does not carry this risk. If you are not sure if your melatonin is natural or synthetic ask your doctor or pharmacist before taking it.Melatonin can be used to treat insomnia (difficulty falling asleep and/or staying asleep). It can also be taken to prevent jet lag. Beyond that there is little scientific evidence that melatonin has a role in promoting health or treating disease. Buy MELOSET MEL and other Prescription Drugs 10 products online at Medstore. 800
About MELOSET MEL: Product Type: Prescription Drugs 10 MELOSET ( MEL MLT Generic Melatonin ) MELOSET (MEL MLT Generic Melatonin) MEL MLT Generic Melatonin 3mg Tabs 30 (3 x 10) MEL MLT Generic Melatonin MELOSET
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
